Figure 1.
![Figure 1. Serial time points analysis of ROCK-1. Assessment of antibody reactivity with ROCK-1 determined by phage-plate assay in serial samples from patient 2 (early responder [ER]) and patient 4 (late responder [LR]). Quantification was based on the intensity of reactivity of the positive plaques.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/103/2/10.1182_blood-2003-07-2559/6/h80245539001.jpeg?Expires=1722437743&Signature=sQU13WlNqkSx3LrmmODGR9e7N4j8JiFysWJ3oJTt6rHq6huRUDlEsyln0PXepeIXpjXd4oNWuFPM3vbL7WZSgIGCVaA5jZVP1CMJ0MmlraRkpA0cx1SV7z-xNmZIZ7x3W2cqZwIWyGP9OM0aeyBFQY1OfhX9HuZnz0zePgmW2GH4NU4omrwJItVaYaH3mgSDR8W6qL~vW2XrJcnM6yaIsLyHAKHX6xXzKmONDNw-yYDx3Zy0AP9s8I7DyJKR-WyvM7z2B3yTm3SsgyimXTwo1fPPw3YDTFPKnhODOsh~DVHKS~Q7AxTQ1HZOV2ZccNUu5~4KraSaZP8KGfDL3KaJpg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Serial time points analysis of ROCK-1. Assessment of antibody reactivity with ROCK-1 determined by phage-plate assay in serial samples from patient 2 (early responder [ER]) and patient 4 (late responder [LR]). Quantification was based on the intensity of reactivity of the positive plaques.
